Table 1 Patients’ characteristics and baseline values
Esketamine group(23) | Control group(24) | P-Value | |
|---|---|---|---|
Age (years) | 51.57 ± 11.96 | 51.04 ± 8.35 | 0.863 |
Sex (male) | 13 (56.5%) | 11 (45.8%) | 0.659 |
Weight (kg) | 67.07 ± 8.45 | 66.52 ± 10.73 | 0.847 |
Hight (cm) | 166.09 ± 7.06 | 163.08 ± 7.16 | 0.155 |
ASA PS | 2 [1 to 2] | 2 [1 to 2] | 0.653 |
Hypertension | 4 (17.4%) | 3 (12.5%) | 0.701 |
Diabetes | 1 (4.3%) | 2 (8.3%) | 1.000 |
Duration procedure (min) | 59.04 ± 21.12 | 58.75 ± 23.41 | 0.964 |
Baseline measurements | |||
SBP (mmHg) | 138.15 ± 23.46 | 134.33 ± 14.89 | 0.514 |
DBP (mmHg) | 80.77 ± 11.35 | 81.80 ± 9.62 | 0.739 |
SpO2 (%) | 99 [97 to 100] | 99 [96 to 100] | 0.797 |
Heart rate (bpm) | 81.92 ± 14.55 | 76.47 ± 9.13 | 0.134 |
Pain (NRS) | 0 [0 to 1] | 0 [0 to 0] | 0.153 |
Nausea (Likert) | 0 [0 to 0] | 0 [0 to 0] | 1.000 |
Vomiting (number) | 0 [0 to 0] | 0 [0 to 0] | 1.000 |